Phase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer Patients

NCT03509584 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped SAFETY

Conditions

Non-small Cell Lung Cancer

Interventions

RADIATION: hypofractionated radiotherapy
DRUG: nivolumab
DRUG: Ipilimumab

Sponsor

Assistance Publique Hopitaux De Marseille